NanoInk and GenUs BioSystems Graduate from Chicago Technology Park
FOR IMMEDIATE RELEASE - August 31, 2005
CHICAGO (August 31, 2005) - The Illinois Medical District Commission (IMDC) today announced that two of its companies located in the Chicago Technology Park, NanoInk and GenUs BioSystems, have graduated and successfully transitioned into their new facilities. Each company occupied lab space in the Chicago Technology Park (CTP) Research Center.
NanoInk, a company that is commercializing technology developed at Northwestern University, has moved its team of scientists into a newly renovated lab at its corporate headquarters, just west of downtown Chicago. NanoInk has been utilizing lab space in the CTP since 1999, developing its Dip Pen Nanolithography(TM) (DPN)(TM) technology. DPN is a method of nanoscale manufacturing that enables NanoInk to build nanometer scale structures and patterns by literally drawing materials directly onto a surface. Although applicable to many industries, the company is focusing its commercialization efforts in brand protection, semiconductor and life science applications.
GenUs BioSystems, now located in Northbrook, Illinois, acquired 2,400 square feet of lab office space to accommodate its expansion. Founded in 2003, Genus BioSystems is exclusively focused on gene expression profiling services using the best available bioarray technology. The company's move to a larger facility was prompted by the addition of new technologies and services and by the continued growth of its customer base.
"Our goal is to help companies achieve the next level of growth, said Samuel Pruett, executive director of the Illinois Medical District Commission (IMDC) and president of the CTP. By providing fully equipped infrastructure, university resources, internship programs, custom designed business development services, and a collaborative life sciences community, we provide a turnkey and proven solution for start-up companies."
The park has successfully graduated 27 companies into the local community. The average growth rate of the companies has been 200% in the past four years. Employment has increased from 80 to 400 over the past five years.
About the Chicago Technology Park
The Chicago Technology Park is a 56-acre research park that fosters the commercialization of innovative technologies through state-of-the-art facilities and critical support services. The CTP is administered by the Illinois Medical District in partnership with the University Of Illinois and Rush University Medical Center. The CTP's Research Center was one of the first biotechnology incubators in the U.S. and is still one of the largest. The CTP is currently home to 30 early- and mid-stage technology-driven companies. For more information visit www.techpark.com
About the Illinois Medical District
The IMD is a public body charged with governing coordinated growth and enhancement of the specially designated 560 acre "district" on the near west side of Chicago. The District was created in 1941 by the Illinois General Assembly and is among the largest of its kind in the world. In addition to urban planning functions, the IMD directly operates the Chicago Technology Park and is redeveloping a 100-acre District Development area. For more information, visit www.imdc.org.
Contact:
Murad Sabzali
630 / 400-3042
E-mail: msabzali@chempetitive.com
Associated File: None
|
